Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSS2300045	注射用重组人凝血因子Ⅷ-Fc融合蛋白	Recombinant Human Coagulation Factor VIII-Fc Fusion Protein	Lyophilized	Biological Products(1)	New Drug Application	2023-06-21					view
CXSB2400122	注射用重组人凝血因子Ⅷ-Fc融合蛋白	Recombinant Human Coagulation Factor VIII-Fc Fusion Protein	Lyophilized	Biological Products(2.4)	Supplementary Application	2024-10-13		Chengdu Rongsheng Pharmaceuticals Co Ltd			view
CXSS2101084	注射用重组人凝血因子Ⅷ-Fc融合蛋白	Recombinant Human Coagulation Factor VIII-Fc Fusion Protein	Lyophilized	Biological Products(1)	New Drug Application	2021-12-23					view
CXSL2300639	注射用重组人凝血因子Ⅷ-Fc融合蛋白	Recombinant Human Coagulation Factor VIII-Fc Fusion Protein	Lyophilized	Biological Products(2.4)	New Drug Application	2023-09-21		Chengdu Rongsheng Pharmaceuticals Co Ltd			view
CXSL2300638	注射用重组人凝血因子Ⅷ-Fc融合蛋白	Recombinant Human Coagulation Factor VIII-Fc Fusion Protein	Lyophilized	Biological Products(2.4)	New Drug Application	2023-09-21		Chengdu Rongsheng Pharmaceuticals Co Ltd			view
CXSS2101083	注射用重组人凝血因子Ⅷ-Fc融合蛋白	Recombinant Human Coagulation Factor VIII-Fc Fusion Protein	Lyophilized	Biological Products(1)	New Drug Application	2021-12-23					view
CXSS2300044	注射用重组人凝血因子Ⅷ-Fc融合蛋白	Recombinant Human Coagulation Factor VIII-Fc Fusion Protein	Lyophilized	Biological Products(1)	New Drug Application	2023-06-21					view
CXSL1700163	注射用重组人凝血因子Ⅷ-Fc融合蛋白	Recombinant Human Coagulation Factor VIII-Fc Fusion Protein	Lyophilized	Biological Products(1)	New Drug Application	2018-03-09	开封制药（集团）有限公司	Kaifeng Pharmaceutical (GROUP) Co Ltd	Certificate Issued	2018-09-25	view
CXSL1700162	注射用重组人凝血因子Ⅷ-Fc融合蛋白	Recombinant Human Coagulation Factor VIII-Fc Fusion Protein	Lyophilized	Biological Products(1)	New Drug Application	2018-03-09	开封制药（集团）有限公司	Kaifeng Pharmaceutical (GROUP) Co Ltd	Certificate Issued	2018-09-25	view